97 related articles for article (PubMed ID: 955740)
1. Impaired general cell-mediated immune functions in vivo and in vitro in patients with nasopharyngeal carcinoma.
Chan SH; Chew TS; Goh EH; Simons MJ; Shanmugaratnam K
Int J Cancer; 1976 Aug; 18(2):139-44. PubMed ID: 955740
[TBL] [Abstract][Full Text] [Related]
2. General immunological status of nasopharyngeal carcinoma patients in Singapore.
Chan SH; Goh EH; Khor TH; Chew TS
IARC Sci Publ (1971); 1978; (20):495-501. PubMed ID: 215531
[TBL] [Abstract][Full Text] [Related]
3. Effect of levamisole on cell-mediated immune responses in patients with nasopharyngeal carcinoma.
Goh EH; Chan SH; Simons MJ
IARC Sci Publ (1971); 1978; (20):503-10. PubMed ID: 730200
[TBL] [Abstract][Full Text] [Related]
4. Immunologic study on nasopharyngeal carcinoma patients: correlation of in vivo and in vitro reactivity to phytohemagglutinin.
Hsu MM; Lo P
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Feb; 16(1):20-32. PubMed ID: 6851721
[TBL] [Abstract][Full Text] [Related]
5. In vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytes.
Ng WS; Ng MH; Ho HC; Lamelin JP
Br J Cancer; 1977 Dec; 36(6):713-22. PubMed ID: 597472
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity in nasopharyngeal carcinoma and allergic rhinitis: a controlled study.
Wong HT; Shahrizal TA; Prepageran N; Lim WK; Raman R
Ear Nose Throat J; 2007 May; 86(5):292-4. PubMed ID: 17580811
[TBL] [Abstract][Full Text] [Related]
7. Immunologic reactivity in patients with nasopharyngeal carcinoma.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Huang SC; Tu SM
Otolaryngol Head Neck Surg; 1980; 88(4):384-90. PubMed ID: 6821420
[TBL] [Abstract][Full Text] [Related]
8. Response of lymphocyte subpopulations to phytohemagglutinin, concanavalin A and pokeweed mitogen in patients with nasopharyngeal carcinoma.
Hsu MM; Lin BL
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Nov; 18(4):224-31. PubMed ID: 3878769
[TBL] [Abstract][Full Text] [Related]
9. Elevated IGA in carcinoma of the nasopharynx.
Wara WM; Wara DW; Phillips TL; Ammann AJ
Cancer; 1975 May; 35(5):1313-5. PubMed ID: 1122483
[TBL] [Abstract][Full Text] [Related]
10. [Lymphocyte proliferation assay of the tumor associated antigen derived from a nasopharyngeal carcinoma cell line (NPC-204)].
Tsukuda M
Nihon Jibiinkoka Gakkai Kaiho; 1982 Aug; 85(8):963-70. PubMed ID: 7143149
[No Abstract] [Full Text] [Related]
11. [Cell-mediated immune function in NPC patients treated with cimetidine].
Zeng P; Xiao J; Lei Y
Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):223-5. PubMed ID: 7656832
[TBL] [Abstract][Full Text] [Related]
12. [Cellular immunity in nasopharyngeal carcinoma cases].
Tsukuda M; Tamamushi N; Mochimatsu I; Mitarai K; Sawaki S
Nihon Jibiinkoka Gakkai Kaiho; 1986 Jan; 89(1):7-13. PubMed ID: 3486262
[No Abstract] [Full Text] [Related]
13. Analyses of the prognostic significance of the Epstein-Barr virus transactivator ZEBRA protein and diagnostic value of its two synthetic peptides in nasopharyngeal carcinoma.
Dardari R; Menezes J; Drouet E; Joab I; Benider A; Bakkali H; Kanouni L; Jouhadi H; Benjaafar N; El Gueddari B; Hassar M; Khyatti M
J Clin Virol; 2008 Feb; 41(2):96-103. PubMed ID: 18024156
[TBL] [Abstract][Full Text] [Related]
14. Lymphoproliferative response to membrane extracts of nasopharyngeal carcinoma.
Tsukuda M; Sawaki S; Yanoma S; Yoshimura N; Takei M; Takada M; Kawamura A
Gan; 1980 Aug; 71(4):441-50. PubMed ID: 6253346
[TBL] [Abstract][Full Text] [Related]
15. Cell-mediated immunity, Epstein-Barr virus and nasopharyngeal carcinoma.
Levine PH; Lamelin JP; Stevens DA
IARC Sci Publ (1971); 1978; (20):483-94. PubMed ID: 215530
[TBL] [Abstract][Full Text] [Related]
16. [The ex vivo expansion of gamma delta T cells from the peripheral blood of patients with nasopharyngeal carcinoma and their cytotoxicity to nasopharyngeal carcinoma lines in vitro].
Wang X; He W; Zhang L; Zhang S; He H; Jiang H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Mar; 17(3):155-8. PubMed ID: 12815895
[TBL] [Abstract][Full Text] [Related]
17. Suppressed cellular immunity in patients with nasopharyngeal carcinoma.
Tsukuda M; Sawaki S; Yanoma S
J Cancer Res Clin Oncol; 1993; 120(1-2):115-8. PubMed ID: 8270600
[TBL] [Abstract][Full Text] [Related]
18. Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan.
Tamada A; Makimoto K; Yamabe H; Imai J; Hinuma Y; Oyagi A; Araki T
Cancer; 1984 Feb; 53(3):430-40. PubMed ID: 6318948
[TBL] [Abstract][Full Text] [Related]
19. Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Tu SM
Taiwan Yi Xue Hui Za Zhi; 1978 Jul; 77(7):549-55. PubMed ID: 308994
[No Abstract] [Full Text] [Related]
20. Association between HLA-A/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia.
Mokni-Baizig N; Ayed K; Ayed FB; Ayed S; Sassi F; Ladgham A; Bel Hadj O; El May A
Oncology; 2001; 61(1):55-8. PubMed ID: 11474249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
